Aster DM Healthcare Slips Most In Nearly Two Years On Q1 Profit Miss
Aster DM Healthcare stock slipped as much as 10.3%—the most since September 2020.
Shares of Aster DM Healthcare Ltd fell the most in nearly two years after the pharma company's profit missed analyst estimates in the quarter ended June.
Key figures (Consolidated, YoY)
Revenue up 12% at Rs 2,662 crore. (Bloomberg estimate: Rs 2,546 crore)
Net profit up 54% to Rs 68.5 crore. (Estimate: Rs 99.6 crore profit)
Ebitda up 4% to Rs 292 crore. (Estimate: Rs 375 crore)
Margin at 11% vs 11.8%. (Estimate: 14.7%)
The stock reversed all the gains it made a day earlier. It slipped as much as 10.3%—the most since September 2020, before closing 8.6% lower.
Of the 10 analysts tracking the company, nine maintain a 'buy' and one suggests a 'hold', according to Bloomberg data. The 12-month consensus price target implies an upside of 11.7%.